A Texas appellate court has reversed a lower court's order allowing for the involuntary administration of psychoactive medication to an individual known as C.D., who was found mentally incompetent to stand trial. The ruling, issued by the Texas Court of Appeals, 2nd District, on October 22, 2026, highlights the legal standards that must be met before such medication can be administered against a person's will.

The case, identified by docket number 02-26-00544-CV, centers on C.D., who was committed to a mental health facility after being charged with a third-degree felony. The court's decision affects not only C.D. but also sets a precedent for how courts evaluate the involuntary administration of medication in similar cases involving mental health.

Background

C.D. was charged with a third-degree felony, and a district court found her mentally incompetent to stand trial. As a result, she was committed to a mental health facility on April 6, 2026. Following her commitment, C.D. was transferred to the North Texas State Hospital, where her treating psychiatrist, Dr. Mohona Sadhu, filed an application on August 10, 2026, seeking authorization to administer psychoactive medication involuntarily.

During a hearing two days later, Dr. Sadhu testified about C.D.'s condition, which included a delusional disorder characterized by fixed beliefs that were not influenced by rational evidence. C.D. believed she was involved in a conspiracy and had been working undercover for the FBI for decades. Despite her mental health issues, Dr. Sadhu noted that C.D. had not exhibited aggression and had consistently refused medication, claiming she did not have a mental illness.

The Ruling

The Texas Court of Appeals ruled that the lower court's order for involuntary medication was not supported by sufficient evidence. The court applied the four-part test established by the U.S. Supreme Court in Sell v. U.S. to determine whether the involuntary administration of medication was constitutionally permissible. The court stated, "Because the Sell test applies, and the evidence does not satisfy the test’s second factor, we reverse and render without reaching Cate’s first sub-issue."

The court found that while the first factor of the Sell test was met—indicating that there are important governmental interests at stake—the second factor was not satisfied. Specifically, there was insufficient evidence that the involuntary medication would significantly further the governmental interests in restoring C.D.'s competency to stand trial. The court noted, "There was no discussion of the medication’s possible side effects at all," which is critical for determining whether the medication could interfere with her ability to assist in her defense.

Impact

This ruling is significant as it underscores the legal protections individuals have against the involuntary administration of medication. It emphasizes the necessity for courts to thoroughly evaluate the evidence and ensure that all criteria are met before allowing such actions. The decision not only affects C.D. but also serves as a precedent for future cases involving mental health and the administration of psychoactive medication.

Involuntary medication can have serious implications for a person's rights and well-being. This ruling reinforces the importance of safeguarding those rights, particularly for individuals who may be vulnerable due to mental health issues. It highlights the need for a careful balance between the state's interest in prosecuting individuals and the individual's rights to make decisions about their own health care.

What's Next

The ruling can potentially be appealed to a higher court, but details about any related cases or further actions were not available in the court filing. As it stands, the Texas Court of Appeals has set a clear standard that must be met for the involuntary administration of psychoactive medication.